568 related articles for article (PubMed ID: 25924179)
1. Employment of vasopressin receptor antagonists in management of hyponatraemia and volume overload in some clinical conditions.
Urso C; Brucculeri S; Caimi G
J Clin Pharm Ther; 2015 Aug; 40(4):376-85. PubMed ID: 25924179
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of vasopressin receptor antagonists.
Ali F; Guglin M; Vaitkevicius P; Ghali JK
Drugs; 2007; 67(6):847-58. PubMed ID: 17428103
[TBL] [Abstract][Full Text] [Related]
3. [Vasopressin antagonists in treatment of hyponatremia].
Olszewski W; Głuszek J
Pol Arch Med Wewn; 2007 Aug; 117(8):356-62. PubMed ID: 18018383
[TBL] [Abstract][Full Text] [Related]
4. Hyponatremia and antidiuresis syndrome.
Vantyghem MC; Balavoine AS; Wémeau JL; Douillard C
Ann Endocrinol (Paris); 2011 Dec; 72(6):500-12. PubMed ID: 22119069
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of hyponatraemia in hospitalised patients.
Reddy P; Mooradian AD
Int J Clin Pract; 2009 Oct; 63(10):1494-508. PubMed ID: 19769706
[TBL] [Abstract][Full Text] [Related]
6. Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Gassanov N; Semmo N; Semmo M; Nia AM; Fuhr U; Er F
Eur J Clin Pharmacol; 2011 Apr; 67(4):333-346. PubMed ID: 21327910
[TBL] [Abstract][Full Text] [Related]
7. Vaptans and hyponatremia in critical patients.
D'Auria D; Marinosci GZ; De Benedictis G; Piazza O
Transl Med UniSa; 2012 May; 3():1-14. PubMed ID: 23905047
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
Ferguson JW; Therapondos G; Newby DE; Hayes PC
Clin Sci (Lond); 2003 Jul; 105(1):1-8. PubMed ID: 12639215
[TBL] [Abstract][Full Text] [Related]
9. [Vasopressin receptor antagonists: the vaptans].
Villabona C
Endocrinol Nutr; 2010 May; 57 Suppl 2():41-52. PubMed ID: 21130961
[TBL] [Abstract][Full Text] [Related]
10. Clinical review: the use of vaptans in clinical endocrinology.
Peri A
J Clin Endocrinol Metab; 2013 Apr; 98(4):1321-32. PubMed ID: 23401044
[TBL] [Abstract][Full Text] [Related]
11. [Current options of treatment of hyponatremia].
Tesař V
Vnitr Lek; 2016; 62 Suppl 6():97-101. PubMed ID: 28124939
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of hyponatraemia in neurosurgical patients.
Cuesta M; Hannon MJ; Thompson CJ
Endocrinol Nutr; 2016 May; 63(5):230-8. PubMed ID: 26965574
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin antagonists: role in the management of hyponatremia.
Yeates KE; Morton AR
Am J Nephrol; 2006; 26(4):348-55. PubMed ID: 16837788
[TBL] [Abstract][Full Text] [Related]
14. Vasopressin-receptor antagonist therapy in patients with hyponatraemia.
Vachharajani T; Vachharajani V
Br J Hosp Med (Lond); 2007 Jul; 68(7):367-72. PubMed ID: 17663307
[TBL] [Abstract][Full Text] [Related]
15. The use of vasopressin receptor antagonists in hyponatremia.
Khanna A; Menon MC
Curr Opin Investig Drugs; 2010 Sep; 11(9):1007-14. PubMed ID: 20730695
[TBL] [Abstract][Full Text] [Related]
16. The role of V2 vasopressin antagonists in hyponatremia.
Palm C; Reimann D; Gross P
Cardiovasc Res; 2001 Aug; 51(3):403-8. PubMed ID: 11476730
[TBL] [Abstract][Full Text] [Related]
17. The syndrome of inappropriate antidiuresis (SIAD).
Cuesta M; Thompson CJ
Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):175-87. PubMed ID: 27156757
[TBL] [Abstract][Full Text] [Related]
18. Hyponatremia in cancer patients.
Platania M; Verzoni E; Vitali M
Tumori; 2015; 101(2):246-8. PubMed ID: 25908038
[TBL] [Abstract][Full Text] [Related]
19. Treatment options for hyponatremia in heart failure.
Goldsmith SR
Congest Heart Fail; 2010 Jul; 16 Suppl 1():S15-8. PubMed ID: 20653706
[TBL] [Abstract][Full Text] [Related]
20. BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats.
Kazama I; Hatano R; Michimata M; Suzuki K; Arata T; Suzuki M; Miyama N; Sato A; Satomi S; Ejima Y; Sasaki S; Matsubara M
Kidney Int; 2005 May; 67(5):1855-67. PubMed ID: 15840033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
